Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Deerfield Group
Accent Therapeutics Presents Data Reinforcing Therapeutic Potential of Novel KIF18A Inhibitor, ATX-295, at the 2026 American Association for Cancer Research Annual Meeting
May 22, 2026
Marengo Reports Late-Breaking Initial Phase 2 Clinical Results from Invikafusp Alfa Plus TRODELVY® and Unveils Partnered Novel IPN01203/STAR0501 STAR Program in Phase 1 at AACR 2026
May 22, 2026
AllRock Bio Doses First Patients in Phase 2a Trial of ROC-101 for Pulmonary Hypertension
May 21, 2026
Deerfield Group Names Bill Veltre as Chief Media Officer
May 21, 2026
Accent Therapeutics to Present Preclinical Data on Lead Clinical Program, ATX-295, at the 2026 American Association for Cancer Research Annual Meeting
May 20, 2026
Petrichor Names Paul Sekhri as Operating Partner
May 20, 2026
Averna Therapeutics Announces Strategic Leadership Expansion
May 18, 2026
GentiBio Announces First Participant Dosed in POLARIS Phase 1 Clinical Trial of GNTI-122 in Recently Diagnosed Type 1 Diabetes
May 17, 2026
Immunitas Therapeutics to Present Clinical Data Supporting Monotherapy and Combination Treatment Potential of IMT-009 at the AACR 2026 Annual Meeting
May 17, 2026
←
Previous Page
1
2